Cargando…
Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells: Current Strategies and Limitations
The capacity of differentiation of human pluripotent stem cells (hPSCs), which include both embryonic stem cells and induced pluripotent stem cells, into cardiomyocytes (CMs) in vitro provides an unlimited resource for human CMs for a wide range of applications such as cell based cardiac repair, car...
Autores principales: | Jiang, Yanqing, Park, Peter, Hong, Sang-Min, Ban, Kiwon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078855/ https://www.ncbi.nlm.nih.gov/pubmed/29890820 http://dx.doi.org/10.14348/molcells.2018.0143 |
Ejemplares similares
-
Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells
por: Ban, Kiwon, et al.
Publicado: (2017) -
Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes
por: Wu, Peng, et al.
Publicado: (2021) -
Disease modeling of desmosome-related cardiomyopathy using induced pluripotent stem cell-derived cardiomyocytes
por: Higo, Shuichiro
Publicado: (2023) -
Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation
por: Leowattana, Wattana, et al.
Publicado: (2022) -
Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes
por: Machiraju, Pranav, et al.
Publicado: (2019)